Gentuity

Gentuity

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

Gentuity is a private, commercial-stage medical technology firm focused on revolutionizing intravascular imaging with its High-Frequency Optical Coherence Tomography (HF-OCT) platform. Its core innovation is the 1.8F Vis-Rx catheter, the smallest of its kind, enabling access to tight lesions without pre-dilation and offering rapid, full-vessel imaging. The company is actively selling its system in the US, Europe, and Japan, and is developing its platform with AI integration to enhance procedural guidance in interventional cardiology.

Cardiovascular Disease

Technology Platform

High-Frequency Optical Coherence Tomography (HF-OCT) intravascular imaging platform featuring the world's smallest (1.8F) imaging catheter, ultra-fast pullback speed, long imaging length, and in-development AI/machine learning software for image analysis.

Funding History

2
Total raised:$30M
Series B$20M
Series A$10M

Opportunities

The growing clinical adoption of intravascular imaging to optimize stent placements presents a large market.
Gentuity's ultra-small catheter uniquely addresses unmet need in accessing tight lesions without pre-dilation.
The integration of AI for automated analysis represents a significant value-add opportunity to improve workflow and decision support.

Risk Factors

Facing intense competition from large, established players in IVUS and OCT.
Must drive changes in physician behavior and workflow to adopt a new platform.
As a private, smaller company, execution risk in global commercialization and scaling is heightened.

Competitive Landscape

Competes against major intravascular imaging companies including Philips (Volcano) and Boston Scientific in IVUS, and Abbott Vascular in OCT. Gentuity's primary differentiation is its significantly smaller catheter size, which targets a specific procedural challenge (tight lesions) not easily addressed by larger competitors.